These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7861017)

  • 1. Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.
    Murray HW; Squires KE; Weiss W; Sledz S; Sacks HS; Hassett J; Cross A; Anderson RE; Dunkle LM
    J Infect Dis; 1995 Mar; 171 Suppl 2():S123-30. PubMed ID: 7861017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
    Skowron G
    J Infect Dis; 1995 Mar; 171 Suppl 2():S113-7. PubMed ID: 7861015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.
    Browne MJ; Mayer KH; Chafee SB; Dudley MN; Posner MR; Steinberg SM; Graham KK; Geletko SM; Zinner SH; Denman SL
    J Infect Dis; 1993 Jan; 167(1):21-9. PubMed ID: 8093363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
    Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.
    Merigan TC; Skowron G; Bozzette SA; Richman D; Uttamchandani R; Fischl M; Schooley R; Hirsch M; Soo W; Pettinelli C
    Ann Intern Med; 1989 Feb; 110(3):189-94. PubMed ID: 2536257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related activity of stavudine in patients infected with human immunodeficiency virus.
    Petersen EA; Ramírez-Ronda CH; Hardy WD; Schwartz R; Sacks HS; Follansbee S; Peterson DM; Cross A; Anderson RE; Dunkle LM
    J Infect Dis; 1995 Mar; 171 Suppl 2():S131-9. PubMed ID: 7861018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Didanosine: long-term follow-up of patients in a phase 1 study.
    Lambert JS; Seidlin M; Valentine FT; Reichman RC; Dolin R
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S40-5. PubMed ID: 8093846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
    Rathbun RC; Martin ES
    Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
    Zamora L; Gatell JM; Barrera JM; Ercilla G; Gil C; Buira E; Miro JM; Soriano E
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1181-5. PubMed ID: 1291319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.
    Connolly KJ; Allan JD; Fitch H; Jackson-Pope L; McLaren C; Canetta R; Groopman JE
    Am J Med; 1991 Nov; 91(5):471-8. PubMed ID: 1659189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.
    Yarchoan R; Mitsuya H; Pluda JM; Marczyk KS; Thomas RV; Hartman NR; Brouwers P; Perno CF; Allain JP; Johns DG
    Rev Infect Dis; 1990; 12 Suppl 5():S522-33. PubMed ID: 1974724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',3'-Dideoxyinosine in patients with AIDS or AIDS-related complex.
    Dolin R; Lambert JS; Morse GD; Reichman RC; Plank CS; Reid J; Knupp C; McLaren C; Pettinelli C
    Rev Infect Dis; 1990; 12 Suppl 5():S540-9; discussion S549-51. PubMed ID: 1974726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily.
    Cooley TP; Kunches LM; Saunders CA; Perkins CJ; Kelley SL; McLaren C; McCaffrey RP; Liebman HA
    Rev Infect Dis; 1990; 12 Suppl 5():S552-60. PubMed ID: 1974727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
    Kline MW; Dunkle LM; Church JA; Goldsmith JC; Harris AT; Federici ME; Schultze ME; Woods L; Loewen DF; Kaul S
    Pediatrics; 1995 Aug; 96(2 Pt 1):247-52. PubMed ID: 7630678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
    Jackson GG; Paul DA; Falk LA; Rubenis M; Despotes JC; Mack D; Knigge M; Emeson EE
    Ann Intern Med; 1988 Feb; 108(2):175-80. PubMed ID: 3124680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.
    Crumpacker C; Heagy W; Bubley G; Monroe JE; Finberg R; Hussey S; Schnipper L; Lucey D; Lee TH; McLane MF
    Ann Intern Med; 1987 Nov; 107(5):664-74. PubMed ID: 3662279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.